alpha-Glycosidase-IN-1 (compound MZ7) is a potent inhibitor of alpha-GLY (alpha-glycosidase) with an IC50 of 44.72 nM and a Ki of 44.74 nM. It also inhibits human carbonic anhydrase isozymes I (hCA I) and II (hCA II) with IC50 values of 104.87 nM and 100.04 nM, respectively, and acetylcholine esterase (AChE) with an IC50 value of 654.87 nM. alpha-Glycosidase-IN-1 is applicable in the study of diabetes, Alzheimers disease, ulcers, heart failure, epilepsy, and various other diseases.